Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Jakarta Timur, DKI Jakarta-based Stem Cell and Cancer Institute operates in Biotechnology Research. Privately held, at kalbe.co.id. It holds one address on record, all in Indonesia. It employs 28 people, on the record. It is listed alongside ten similar brands, mostly in Biotechnology Research.
PT. Kalbe Farma Tbk. - Stem Cell and Cancer Institute (SCI) was established December 1st, 2006 as an extension to Kalbe's high-tech Research and Development Center.
SCI and PT. Kalbe Farma Tbk. combined their forces to help improve people's health for a better life. SCI operates as an independent center within Kalbe group.
Our vision is to be the best integrated R&D institute in personalized medicine and cell therapy in Indonesia and beyond, and our mission is to improve the quality of life in ethical and responsible manner by conducting translational research and cell therapy development through multi-disciplinary collaborations.
| Countries | 1 |
|---|---|
| Primary country | ID |
All codes: ID
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
28 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Indonesia only. Primary: Jl. Jenderal Ahmad Yani Jl. Pulo Mas No.2, RT.3/RW.13, Kayu Putih, Kec. Pulo Gadung, Kota Jakarta Timur, Daerah Khusus Ibukota Jakarta 13210, Jakarta Timur, DKI Jakarta 13210.
None linked to this brand.
12 profiles list Stem Cell and Cancer Institute as a peer — 85th percentile in Biotechnology Research. It lists ten peers of its own. Biotis Pharmaceuticals Indonesia and PT. SCCR INDONESIA list it back.